[Novelties in the field of progression factors in chronic kidney disease]

Nefrologia. 2008:28 Suppl 5:105-11.
[Article in Spanish]

Abstract

The fight against chronic kidney disease is one of the most relevant aspects of nephrological practice, from both the perspective of clinical activity and research within the field of nephrology. In this brief article, we present in very summarized form some of the aspects in this field in the last year that the authors found of interest. Because the content of the next few pages was necessarily chosen on the basis of the authors' preferences, we assume that many other topics of great interest have been left out of this summary. In any case, we hope that this article will be interesting and useful and also serve as an subject of debate in nephrology forums.

Publication types

  • Review

MeSH terms

  • Adult
  • Amidohydrolases / genetics
  • Amidohydrolases / physiology
  • Animals
  • Arginine / analogs & derivatives
  • Arginine / blood
  • Carbon / therapeutic use
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / etiology
  • Chronic Disease
  • Clinical Trials as Topic
  • Disease Progression
  • Female
  • Genetic Therapy
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Infant, Low Birth Weight
  • Infant, Newborn
  • Kidney Diseases / drug therapy
  • Kidney Diseases / embryology
  • Kidney Diseases / metabolism
  • Kidney Diseases / physiopathology*
  • Male
  • Oxides / therapeutic use
  • Pregnancy
  • Prenatal Exposure Delayed Effects
  • Rats
  • Uremia / metabolism
  • Uric Acid / blood

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Oxides
  • Uric Acid
  • N,N-dimethylarginine
  • Carbon
  • AST 120
  • Arginine
  • Amidohydrolases
  • dimethylargininase